Walgreens Boots Alliance — Non-Deal Roadshow (November 2015)
28 slides from Walgreens Boots Alliance's roadshow presentation, Nov 2, 2015

Slide 1: Investor Roadshow materials November 2015
Walgreens Boots Alliance Investor Roadshow materials November 2015 Exhibit 99.1

Slide 2: Safe Harbor and Non-GAAP
Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on our current market, competitive and regulatory expectations and are subject to risks and uncertainties that could cause actual results to vary materially. Except to

Slide 3: Agreement to acquire Rite Aid
Walgreens Boots Alliance Agreement to acquire Rite Aid IR Roadshow - November 2015

Slide 4: Transaction rationale: Agreement to acquire Rite Aid
† Forward-Looking Statements – see cautionary note in attached Appendix. Economies of scale create efficiencies and cost savings Provides opportunity to develop the Rite Aid retail product offering Shift to improve category mix Expand distribution of exclusive global beauty brands including No.7, So

Slide 5: Transaction rationale: expands footprint and fills coverage gaps
† Forward-Looking Statements – see cautionary note in attached Appendix. Transaction rationale Agreement to acquire Rite Aid† Expands store footprint and fills coverage gaps Expanding distribution of exclusive global beauty brands including No.7, Soap & Glory, Botanics and Liz Earle Improves WBA ret

Slide 6: Agreement to acquire Rite Aid: Transaction overview
Agreement to acquire Rite Aid† † Forward-Looking Statements – see cautionary note in attached Appendix. Transaction overview $9.00 per share in cash, total enterprise value of $17.2 billion Subject to approval by Rite Aid shareholders, regulatory clearances and other customary closing conditions Con

Slide 7: Full Year 2015 / 4th Quarter 2015 Earnings
IR Roadshow - November 2015 Walgreens Boots Alliance Full Year 2015 / 4th Quarter 2015 Earnings

Slide 8: Walgreens Boots Alliance consolidated results – FY15
$ in millions (except diluted and adjusted diluted EPS) Walgreens Boots Alliance consolidated results – FY15 1. Net Earnings and Earnings per share figures are attributable to Walgreens Boots Alliance, Inc. 2. All periods presented adjusted for: acquisition-related amortization, LIFO provision, Alli

Slide 9: Walgreens Boots Alliance consolidated results – 4Q15
$ in millions (except diluted and adjusted diluted EPS) Walgreens Boots Alliance consolidated results – 4Q15 GAAP 4Q15 4Q14 Net Sales $28,522 $19,057 Operating Income $836 $986 Interest Expense, net $255 $43 Net Earnings1 $26 ($221) Diluted EPS1 $0.02 ($0.23) Non-GAAP3 4Q152 4Q142 Adjusted Operating

Slide 10: Cash flows and capital deployment
Cash flows and capital deployment 1. Non-GAAP financial measures– see attached Appendix. 2. Under the August 2014 $3 billion authorization for repurchases through the end of fiscal year 2016. Cash Flow FY15 4Q15 GAAP Operating Cash Flow $5.7 billion $1.5 billion Key financing activities Free Cash Fl

Slide 11: Outlook
IR Roadshow - November 2015 Walgreens Boots Alliance Outlook

Slide 12: Outlook: Fiscal year 2016 guidance
Outlook: Fiscal year 2016 guidance† 1. Non-GAAP financial measure – see attached Appendix. † Forward-Looking Statements – see cautionary note in attached Appendix. Metric Guidance† Adjusted EPS1 $4.25 - $4.55 Factors in suspension of activity under $3.0 billion share buyback program Expectation of g

Slide 13: Well Positioned for the Future
Well Positioned for the Future

Slide 14: Non-GAAP financial measures reconciliations
The following information provides reconciliations of the supplemental non-GAAP financial measures, as defined under SEC rules, presented in this presentation to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles in th

Slide 15: 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15.
Reconciliation of Non-GAAP financial measures 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15. Net investment hedge gains of $10 million or $0.01 cent per share in 2Q15 and $7 million or $0.01 cent per share in 3Q15 were included in our GAAP and adj

Slide 16: 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15.
Reconciliation of Non-GAAP financial measures 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15. Net investment hedge gains of $10 million or $0.01 cent per share in 2Q15 and $7 million or $0.01 cent per share in 3Q15 were included in our GAAP and adj

Slide 17: Reconciliation of Non-GAAP financial measures
Reconciliation of Non-GAAP financial measures

Slide 18: Reconciliation of Non-GAAP financial measures
Reconciliation of Non-GAAP financial measures

Slide 19: 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15.
Reconciliation of Non-GAAP financial measures 1. Net investment hedge gains/losses are reported as an adjustment prospectively beginning in 4Q15. Net investment hedge gains of $10 million or $0.01 cent per share in 2Q15 and $7 million or $0.01 cent per share in 3Q15 were included in our GAAP and adj

Slide 20: Reconciliation of Non-GAAP financial measures
Reconciliation of Non-GAAP financial measures

Slide 21: Reconciliation of Non-GAAP financial measures
Reconciliation of Non-GAAP financial measures

Slide 22: Reconciliation of Non-GAAP financial measures
Reconciliation of Non-GAAP financial measures

Slide 23: Reconciliation of Non-GAAP financial measures
Reconciliation of Non-GAAP financial measures

Slide 24: Reconciliation of Non-GAAP financial measures
Reconciliation of Non-GAAP financial measures

Slide 25: Reconciliation of Non-GAAP financial measures
Reconciliation of Non-GAAP financial measures

Slide 26: Free cash flow definition
1. Free cash flow is defined as net cash provided by operating activities in a period minus additions to property, plant and equipment (capital expenditures) made in that period. This measure does not represent residual cash flows available for discretionary expenditures as the measure does not dedu

Slide 27: Certain definitions and assumptions
Certain definitions and assumptions Certain Assumptions: Unless the context otherwise indicates or requires: This presentation assumes constant currency exchange rates after the date hereof based on current rates; All financial estimates and goals assume constant currency exchange rates after the da

Slide 28: Cautionary note regarding forward-looking statements
Cautionary note regarding forward-looking statements Cautionary Note Regarding Forward-Looking Statements: All statements in these materials and the related presentation that are not historical including, without limitation, estimates of and goals for future financial and operating performance, the
Source: SEC EDGAR · 8-K filed Nov 2, 2015
More decks from Walgreens Boots Alliance Inc
Merger or Acquisition (March 2025)10 slides · Mar 7, 2025
Merger or Acquisition (March 2025)7 slides · Mar 7, 2025
Merger or Acquisition (March 2025)10 slides · Mar 6, 2025
Q1 2025 Earnings Presentation31 slides · Jan 10, 2025
Q4 2024 Earnings Presentation43 slides · Oct 15, 2024
Q3 2024 Earnings Presentation36 slides · Jun 27, 2024